Menu Back to Poster-Presentations-Details
T 12: Special Safety Considerations for Gene Therapy Products in Global Clinical Development
- Senior Director, Regulatory Affairs
A review of regulatory guidance and legislation from regulatory bodies in North America, Europe and World Health Organization were reviewed. Guidance and legislation were included from FDA, EMA and ICH.